HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Cholesterol pneumonitis — Clinical Guidelines

Overview

Cholesterol pneumonitis, often part of cholesterol embolization syndrome (CES), results from emboli composed of cholesterol crystals originating from atherosclerotic plaques, leading to multi-organ dysfunction including pulmonary involvement. It typically manifests insidiously with non-specific symptoms and carries a high mortality rate 1 4 5.

Diagnosis

Clinical Presentation: Cutaneous manifestations (livedo reticularis, livedo appearing as cyanotic toes), abdominal pain, myalgias, and multi-organ failure including renal insufficiency 1 4 5.

Supporting Tests:

- Histology: Demonstrates atheroembolic lesions in affected organs (e.g., kidneys, spleen, colon) 6. - Skin Biopsy: Can confirm the presence of cholesterol crystals 7. - Fundoscopic Examination: Reveals characteristic retinal changes 8.

Diagnostic Criteria: No universally accepted criteria; diagnosis often clinical with supportive imaging and pathology findings 1 5 7 8.

Management

Discontinuation of Anticoagulants: Essential if recent catheterization or thrombolytic therapy 8.

Antihyperlipidemic Therapy:

- Cholestyramine: To reduce cholesterol levels 8. - Probucol: Another option to manage hyperlipidemia 8.

Hemostatic Agents:

- Carbazochrome: For bleeding control 8. - Tranexamic Acid: To manage hemorrhagic manifestations 8. - Reptilase: Used in severe bleeding scenarios 8. - Vitamin K: For coagulation factor deficiencies 8.

Supportive Care: Includes management of organ dysfunction (e.g., dialysis for renal failure) 5 8.

Special Populations

Comorbidities: Severe aortic atherosclerosis is a significant risk factor 4 6 8.

No Specific Guidance: Limited data on pregnancy, pediatrics, or elderly-specific management 1 2 3 4 5 6 7 8.

Key Recommendations

Awareness and Early Recognition: Increase clinical suspicion for cholesterol embolization syndrome, especially post-procedural (e.g., cardiac surgery, angiography) 1 4 5 (Evidence: Expert opinion).

Discontinue Anticoagulants: If recent catheterization or thrombolysis, discontinue anticoagulants to prevent further embolization 8 (Evidence: Weak).

Supportive and Specific Therapy: Implement supportive care measures and consider specific treatments like cholestyramine and hemostatic agents to manage symptoms and prolong survival 8 (Evidence: Weak).

References

1 Duman N, Sahin S. Lesson of the month 1: sudden onset postural livedo reticularis, cyanotic toes and multiorgan failure. Clinical medicine (London, England) 2014. link 2 Rakheja D, Boriack RL. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2008. link 3 Mascrez B, Ghyselinck NB, Watanabe M, Annicotte JS, Chambon P, Auwerx J et al.. Ligand-dependent contribution of RXRbeta to cholesterol homeostasis in Sertoli cells. EMBO reports 2004. link 4 Vazquez-Jimenez JF, Pérez-Bouza A, Liakopoulos OJ, Messmer BJ. Cholesterol crystal embolization after cardiac operations. Report of two cases. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2001. link00616-3) 5 Geroulakos G, Homer-Vanniasinkam S, Wilkinson A, Galloway I. Cholesterol embolisation. A lethal complication of instrumentation of an aneurysmal aorta: a case report. International angiology : a journal of the International Union of Angiology 1997. link 6 Macheras A, Mandrekas D, Fotinou M. Multiple cholesterol embolism: a case report. The Journal of cardiovascular surgery 1997. link 7 Turakhia AK, Khan MA. Splinter hemorrhages as a possible clinical manifestation of cholesterol crystal embolization. The Journal of rheumatology 1990. link 8 Kawakami Y, Hirose K, Watanabe Y, Tomioka N, Doyama K, Morikawa M et al.. Management of multiple cholesterol embolization syndrome--a case report. Angiology 1990. link 9 Brodie SW, Chaurasia MK. A rare intracranial complication of cholesterol granuloma. The Journal of laryngology and otology 1985. link

Cholesterol pneumonitis